"Nov. 6, 2012 -- The FDA has approved Pfizer's Xeljanz (tofacitinib), a first-of-its-kind treatment for rheumatoid arthritis.
Xeljanz is approved for use by patients not helped by methotrexate, the usual first treatment for RA. It's a "...
Kineret Patient Information including How Should I Take
In this Article
- What is anakinra (Kineret)?
- What are the possible side effects of anakinra (Kineret)?
- What is the most important information I should know about anakinra (Kineret)?
- What should I discuss with my healthcare provider before using anakinra (Kineret)?
- How should I use anakinra (Kineret)?
- What happens if I miss a dose (Kineret)?
- What happens if I overdose (Kineret)?
- What should I avoid while using anakinra (Kineret)?
- What other drugs will affect anakinra (Kineret)?
- Where can I get more information?
What should I discuss with my healthcare provider before using anakinra (Kineret)?
In rare cases, people receiving anakinra have developed serious infections. Notify your doctor immediately if you develop a fever, flu-like symptoms, or any other sign of infection. Treatment with anakinra should not be started in patients with active infections or those taking other medicines that may suppress the immune system. The use of anakinra in combination with etanercept (Enbrel), infliximab (Remicade), adalimumab (Humira), or other medicines used to treat rheumatoid arthritis, may also increase the risk of a serious infection.
Do not use anakinra without first talking to your doctor if you
- are currently taking etanercept (Enbrel), infliximab (Remicade), or adalimumab (Humira) to treat rheumatoid arthritis;
- have an active infection or a history of recurrent infection;
- have recently been exposed to varicella (chickenpox) virus;
- have a bone marrow disease;
- have a suppressed immune system due to a medical condition or treatment with medication;
- have recently received a live vaccine; or
- have kidney disease.
You may not be able to use anakinra, or you may require a dosage adjustment or special monitoring during treatment.
Anakinra is in the FDA pregnancy category B. This means that it is not expected to harm an unborn baby. Do not use anakinra without first talking to your doctor if you are pregnant or could become pregnant during treatment.
It is not known whether anakinra passes into breast milk. Do not use anakinra without first talking to your doctor if you are breast-feeding a baby.
The safety and effectiveness of anakinra have not been established for pediatric patients.
How should I use anakinra (Kineret)?
Use anakinra exactly as directed by your doctor. If you do not understand these directions, ask your doctor, nurse, or pharmacist to explain them to you.
Anakinra is used as a subcutaneous (under the skin) injection only. Your doctor or nurse will give you detailed instructions on how and where to inject anakinra. Do not inject this medication if you are unsure how.
Anakinra is usually injected once a day. The dose should be injected at approximately the same time every day.
The medication may be allowed to reach room temperature by removing it from the refrigerator about 60 to 90 minutes before administration. This may reduce discomfort during or following the injection.
The medication can be injected into the outer thighs, stomach, back of the upper arms, or buttocks. Rotate the injection site daily to reduce the possibility of soreness or redness. The area of the body being injected does not need to change daily, however each injection site should be at least one inch from the previous day's injection site.
Do not inject anakinra if it is discolored, cloudy, or if it has particles in it. Do not shake the prefilled syringe and do not use anakinra beyond the expiration date shown on the carton. If the solution appears foamy, allow it to sit for a few minutes until it clears.
This medication does not contain a preservative. Therefore, throw away any medication remaining in the syringe after a dose. Do not save the medication for later use.
Never reuse a needle or syringe. Dispose of all needles and syringes in an appropriate, puncture-resistant disposal container.
Your doctor may want you to have blood tests or other medical evaluations during treatment with anakinra to monitor progress and side effects.
Anakinra should be used on a regular basis to get the most benefit.
Store anakinra in the refrigerator (36 to 46 degrees Fahrenheit/2 to 8 degrees Celsius) away from moisture, heat and light. Do not allow anakinra to freeze.
Additional Kineret Information
- Kineret Drug Interactions Center: anakinra subq
- Kineret Side Effects Center
- Kineret Overview including Precautions
- Kineret FDA Approved Prescribing Information including Dosage
Kineret - User Reviews
Kineret User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options